WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Price
Valuation Score
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
FONR
FONAR CORP
$16.31N/AN/A8.63xN/A1.03x0.67xN/A$12.25M11.66%$163.89M25.46$92.05M3.57
ICLR
ICON PLC
$309.02$137.85124.17%37.23x21.21x3.10x2.71x1.17x$1.17B4.59%$9.43B114.23$28.80B17.77
STRR
STAR EQUITY HOLDINGS INC
$0.90$22.88-96.07%0.56xN/A0.31x0.22x0.02x$3.23M23.00%$65.30M4.18-$1.07M-0.04
RVTY
REVVITY INC
$100.61$68.8546.13%18.10x14.56x4.52x1.58x0.92x$9.90M0.08%$7.87B63.73$15.55B12.48
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$233.47$189.5823.15%25.19x16.09x2.90x3.33x0.59x$365.37M3.05%$3.60B70.22$14.78B14.40
NEOG
NEOGEN CORP
$12.02$3.43250.64%601.00x19.08x2.80x0.83x1.27x-$12.98M-0.50%$3.15B14.53$3.33B17.65
IDXX
IDEXX LABORATORIES INC
$480.60$84.40469.42%46.08x43.34x10.72x25.30x6.19x$796.79M2.00%$1.57B18.88$40.34B32.49
TMO
THERMO FISHER SCIENTIFIC INC
$572.38$366.2556.28%36.57x21.14x5.15x4.80x0.71x$7.65B3.50%$45.52B119.15$248.60B21.86
ENZ
ENZO BIOCHEM INC
$1.04$23.75-95.62%1.55xN/A4.09x0.75x0.02x-$45.92M-87.40%$70.78M1.40$139.76k0.00
A
AGILENT TECHNOLOGIES INC
$139.45$70.9696.52%33.05x23.20x6.07x6.60x1.02x$1.65B4.04%$6.19B21.12$41.67B24.66
QGEN
QIAGEN NV
$42.98$21.5099.87%29.28x17.23x4.96x2.67x1.12x$367.58M3.82%$3.60B16.08$10.61B15.60
DGX
QUEST DIAGNOSTICS INC
$137.38$80.4070.86%18.24x15.58x1.64x2.37x1.23x$947.00M6.21%$6.43B57.95$20.14B11.83
SHC
SOTERA HEALTH CO
$11.02$30.53-63.90%58.00x8.96x2.88x7.26x0.13x-$376.77M-12.12%$429.39M1.52$5.20B12.21
DHR
DANAHER CORP
$248.38$151.7463.69%41.67x21.28x8.17x3.44x0.73x$5.57B3.03%$53.44B72.16$195.10B25.88
MEDP
MEDPACE HOLDINGS INC
$392.57$56.17598.92%38.60x53.78x6.17x18.11x392.96x$473.34M3.91%$671.54M21.77$11.89B29.30
WAT
WATERS CORP
$321.25$161.4199.02%29.55x22.03x6.42x16.53x1.11x$442.18M2.33%$1.15B19.47$21.07B21.04
LH
LABORATORY CORP OF AMERICA HOLDINGS
$201.32$230.88-12.80%39.47x10.08x1.38x2.13x0.35x$683.20M4.03%$7.96B94.43$22.84B14.71
MTD
METTLER TOLEDO INTERNATIONAL INC
$1,251.95$534.83134.09%34.68x25.88x7.22x-179.34x1.30x$861.39M3.15%-$149.94M-6.86$28.90B24.65
FLGT
FULGENT GENETICS INC
$21.50N/AN/A-3.86x-27.92x2.23x0.57xN/A$18.78M2.93%$1.13B37.96$589.11M-4.62
SERA
SERA PROGNOSTICS INC
$10.85N/AN/A-9.35xN/A1,085.00x5.01xN/A-$27.01M-7.98%$70.16M2.25$349.22M-10.05
CSTL
CASTLE BIOSCIENCES INC
$24.33N/AN/A-21.34x-11.21x2.67x1.67xN/A-$6.44M-0.96%$402.46M14.64$613.79M-34.36
PRE
PRENETICS GLOBAL LTD
$5.23N/AN/A-0.94xN/A2.94x0.31xN/A-$13.43M-21.05%$206.36M16.91$20.50M-0.37
IQV
IQVIA HOLDINGS INC
$223.37$118.6388.29%30.10x18.40x2.70x6.42x1.00x$1.62B4.00%$6.34B34.88$52.99B16.21
NTRA
NATERA INC
$96.98N/AN/A-25.66x-30.79x10.30x15.30xN/A-$286.15M-2.57%$765.33M6.66$11.50B-30.00
PSNL
PERSONALIS INC
$1.54N/AN/A-0.68x-0.70x1.01x0.60xN/A-$67.17M-90.52%$129.44M2.69$59.11M-0.62
PRPO
PRECIPIO INC
$5.80N/AN/A-1.29xN/A0.50x0.57xN/A-$3.69M-48.95%$14.43M11.12$7.91M-1.83
DRIO
DARIOHEALTH CORP
$1.57N/AN/A-0.81x-0.81x2.19x0.80xN/A-$30.96M-69.49%$58.14M2.05$38.97M-0.72
OLK
OLINK HOLDING AB (PUBL)
$23.01N/AN/A-92.04x460.20x16.87x5.69xN/A-$48.97M-1.71%$502.70M4.04$2.77B-138.02
ACRS
ACLARIS THERAPEUTICS INC
$1.36N/AN/A-1.07x-0.86x3.04x0.61xN/A-$79.63M-83.90%$157.18M2.25$57.01M-0.65
NEO
NEOGENOMICS INC
$15.30N/AN/A-23.18x-30.60x3.16x2.12xN/A-$39.59M-2.05%$923.41M7.32$2.23B1,681.95
DMTK
DERMTECH INC
$0.63N/AN/A-0.20x-0.19x1.34x0.38xN/A-$77.88M-379.33%$57.18M1.75$35.96M-0.38
TWST
TWIST BIOSCIENCE CORP
$41.21N/AN/A-12.26x-11.02x8.58x4.28xN/A-$95.52M-4.01%$560.13M9.69$2.25B-14.46
STIM
NEURONETICS INC
$3.81N/AN/A-3.63x-4.43x1.53x3.32xN/A-$34.41M-31.52%$34.19M1.19$116.17M-5.10
EXAS
EXACT SCIENCES CORP
$62.07N/AN/A-54.93x-27.46x4.47x3.58xN/A$31.93M0.29%$3.15B17.46$13.22B253.20
BGLC
BIONEXUS GENE LAB CORP
$0.60N/AN/A-3.30xN/A0.98x1.10xN/A-$1.45M-15.07%$9.66M0.61$8.19M-3.30
RDNT
RADNET INC
$51.20$13.88268.79%1,024.00x96.60x2.01x5.56x1.32x$44.35M1.36%$630.70M9.92$4.65B17.53
OCX
ONCOCYTE CORP
$2.66N/AN/A-0.71x0.95x13.57x1.08xN/A-$23.25M-114.25%$20.47M2.68$13.74M-0.53
BNR
BURNING ROCK BIOTECH LTD
$0.81N/AN/A-0.91x-1.06x1.11x0.78xN/A-$36.49M-44.11%$106.28M1.04-$718.11k0.01
APDN
APPLIED DNA SCIENCES INC
$3.75N/AN/A-0.34x0.06x0.28x0.75xN/A-$7.67M-299.20%$4.23M6.19$191.78k-0.03
LAB
STANDARD BIOTOOLS INC
$2.51N/AN/A-2.67xN/A1.87x-4.92xN/A-$46.12M-23.23%-$148.05M-1.87$774.70M-11.80
XGN
EXAGEN INC
$1.40N/AN/A-1.04x-1.04x0.47x1.06xN/A-$15.27M-61.64%$22.69M1.28$10.87M-0.60
XWEL
XWELL INC
$1.79N/AN/A-0.27xN/A0.25x0.58xN/A-$17.98M-240.56%$13.00M3.11$9.39M-0.39
GH
GUARDANT HEALTH INC
$18.88N/AN/A-4.41x-3.74x3.75x14.48xN/A-$345.46M-16.34%$158.68M1.42$2.49B-5.75
CDNA
CAREDX INC
$9.72N/AN/A-2.75x-18.34x1.86x1.93xN/A-$26.73M-5.11%$261.33M4.86$448.78M-2.46
BDSX
BIODESIX INC
$1.40N/AN/A-2.19x-3.04x2.34x29.63xN/A-$45.93M-39.93%$4.58M0.06$170.13M-4.59
CHEK
CHECK-CAP LTD
$2.20N/AN/A-0.73x-0.92xN/A0.47xN/A-$17.74M-137.82%$27.40M4.68$9.39M-0.49
ME
23ANDME HOLDING CO
$0.50N/AN/A-0.45xN/A0.97x0.64xN/A-$194.26M-80.48%$377.19M0.78$77.43M-0.16
ULS
UL SOLUTIONS INC
$35.40N/AN/A27.23xN/A2.64xN/AN/A$252.00M3.56%$654.00M3.27N/AN/A
PRPH
PROPHASE LABS INC
$5.42N/AN/A-5.53x6.95x2.10x1.98xN/A-$14.46M-15.50%$49.38M2.87$117.04M-7.89
NDRA
ENDRA LIFE SCIENCES INC
$0.33N/AN/A-0.21xN/AN/A0.64xN/A-$9.57M-459.94%$5.66M0.89$1.17M-0.12
OPK
OPKO HEALTH INC
$1.30N/AN/A-5.20x-10.83x1.13x0.65xN/A-$41.76M-4.31%$1.39B1.85$1.12B-17.05
NOTV
INOTIV INC
$4.27N/AN/A-3.28xN/A0.19x0.43xN/A$6.48M5.88%$254.16M9.87$516.65M8.67
AWH
ASPIRA WOMEN's HEALTH INC
$3.21N/AN/A-1.77x-0.52x3.24x-16.75xN/A-$15.92M-53.71%-$2.37M-0.26$39.62M-2.40
MDXH
MDXHEALTH SA
$3.14N/AN/A-0.23x-2.47x0.11x-8.81xN/A-$24.92M-290.89%-$973.00k-0.36$101.78M-4.76
VNRX
VOLITIONRX LTD
$0.89N/AN/A-1.78xN/A81.00x-9.37xN/A-$19.15M-30.19%-$7.80M-0.11$58.25M-1.73
GENE
GENETIC TECHNOLOGIES LTD
$2.26N/AN/A-0.76xN/A0.08x0.17xN/A-$5.00M-1,152.02%$3.15M16.35-$1.67MN/A
ISPC
ISPECIMEN INC
$0.26N/AN/A-0.21xN/A0.24x0.25xN/A-$10.55M-443.73%$9.74M1.08$242.58k-0.03
MYGN
MYRIAD GENETICS INC
$19.47N/AN/A-6.12xN/A2.14x2.23xN/A-$184.20M-11.43%$783.20M9.46$1.77B-9.51
BIAF
BIOAFFINITY TECHNOLOGIES INC
$2.09N/AN/A-2.30xN/A7.21x4.96xN/A-$6.06M-33.16%$4.86M0.56$22.82M-2.99
ILMN
ILLUMINA INC
$117.93N/AN/A-14.47x20.30x4.17x3.28xN/A$366.00M1.95%$5.73B36.06$19.87B-31.04
PMD
PSYCHEMEDICS CORP
$2.55N/AN/A-3.54xN/A0.66x2.19xN/A-$1.64M-11.18%$6.67M1.16$14.98M-19.50
TRIB
TRINITY BIOTECH PLC
$1.80N/AN/A-0.56xN/A0.24x-0.58xN/A-$14.57M-105.49%-$23.95M-3.12$77.55M-6.90
MYNZ
MAINZ BIOMED NV
$0.74N/AN/A-0.45xN/A13.40x4.80xN/A-$23.84M-199.19%$3.25M0.20$14.92M-0.61
MMA
ALTA GLOBAL GROUP LTD
$3.55N/AN/A-0.68xN/A23.67xN/AN/A-$5.92M-16.31%-$69.50M-6.80N/AN/A
CNTG
CENTOGENE NV
$0.44N/AN/A-0.28xN/A0.22x-0.74xN/A-$28.26M-231.15%-$16.55M-0.60$61.96M-1.40
TTOO
T2 BIOSYSTEMS INC
$3.72N/AN/A-0.19xN/A1.35x-0.73xN/A-$48.33M-497.77%-$28.04M-10.74$53.76M-1.26

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in May 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the top diagnostic & research stock with a Zen Score of 47, which is 20 points higher than the diagnostic & research industry average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 3.69% over the past year, overperforming other diagnostic & research stocks by 4 percentage points.

2. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the second best diagnostic & research stock with a Zen Score of 47, which is 20 points higher than the diagnostic & research industry average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 66.35% over the past year, overperforming other diagnostic & research stocks by 67 percentage points.

Icon has an average 1 year price target of $344.38, an upside of 11.44% from Icon's current stock price of $309.02.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Icon, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the third best diagnostic & research stock with a Zen Score of 46, which is 19 points higher than the diagnostic & research industry average of 27. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 37.4% over the past year, overperforming other diagnostic & research stocks by 38 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 2.98%, which is 2 percentage points higher than the diagnostic & research industry average of 1.36%.

Qiagen Nv's dividend payout ratio of 87.2% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.1%, which is 1 percentage points higher than the diagnostic & research industry average of 1.36%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.43%, which is the same as the diagnostic & research industry average of 1.36%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 56.5% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks up?

Diagnostic & research stocks were up 0.85% in the last day, and up 0.7% over the last week. Twist Bioscience was the among the top gainers in the diagnostics & research industry, gaining 28.74% yesterday.

Twist Bioscience shares are trading higher after the company reported better-than-expected Q2 financial results.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 37.4% in the past year. It has overperformed other stocks in the diagnostic & research industry by 38 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -59.85% in the past year. It has underperformed other stocks in the diagnostic & research industry by -59 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has gained 3.69% in the past year. It has overperformed other stocks in the diagnostic & research industry by 4 percentage points.

Are diagnostic & research stocks a good buy now?

52.08% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 10.51% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.44x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.